FDA Drug Application (022256) for SAVELLA by CYPRESS BIOSCIENCE

Back to FDA Applications sponsored by CYPRESS BIOSCIENCE

Application Number022256
Product Number001
FormTABLET;ORAL
Dosage12.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSAVELLA
Active IngredientMILNACIPRAN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient MILNACIPRAN HYDROCHLORIDE2


Back to FDA Applications sponsored by CYPRESS BIOSCIENCE